Description:

ODM derived from http://clinicaltrials.gov/show/NCT00255281

Link:

http://clinicaltrials.gov/show/NCT00255281

Keywords:
Versions (2) ▾
  1. 2/24/12
  2. 6/6/17
Uploaded on:

June 6, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years to 80 Years
Clinical indication for cardioversion of Atrial Fibrillation
Effective oral anticoagulation according to local routines
TEE without any finding of intracardial thrombus or signs of thrombogenecity
Exclusion Criteria
Clinically significant sinus node dysfunction.
Clinically significant AV node dysfunction.
Serum or plasma potassium <3.8 mmol/L or >5.0 mmol/L
QTc(Bazett) >450 ms
QRS duration >150 ms